TITLE

Personalized medicine: A transformative approach is needed

AUTHOR(S)
Hudson, Thomas J.
PUB. DATE
April 2009
SOURCE
CMAJ: Canadian Medical Association Journal;4/28/2009, Vol. 180 Issue 9, p911
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article the author reflects on the transformative approach needed to improve personalized medicine in Canada. He explains that Canada has an outstanding research community that offers insight on the causes of human diseases through sequencing of human genome, mutations, and biomarkers. He cites the things to be addressed to integrate new genomic knowledge in clinical trials, and research on areas to be improved for its efficient implementation in health care system.
ACCESSION #
38217625

 

Related Articles

  • Redesigning Clinical Trials Necessary to Improve Odds of Finding Effective Targeted Agents in the Genomic Era. Kurzrock, Razelle // Personalized Medicine in Oncology;Nov2013, Vol. 2 Issue 7, p366 

    Information on advances in tumor biomarkers and their use in managing tumors and hematologic malignancies discussed at the 2013 Global Biomarkers Consortium conference is presented. A patient-centric approach in clinical trial design in oncology will be required in determining optimal...

  • Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Zenklusen, Jean C; Hodges, Leslie C; LaCava, Margaret; Green, Eric D; Conti, Claudio J // Oncogene;3/23/2000, Vol. 19 Issue 13, p1729 

    We have previously shown that loss of heterozygosity (LOH) on human chromosome (hchr) 7 at q31.1 is common in a variety of tumors of epithelial origin. Frequent LOH of a specific chromosomal marker is indicative of a closely linked tumor suppressor gene (TSG). However, recent reports have also...

  • PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics. Gámez-Pozo, Angelo; Sánchez-Navarro, Iker; Calvo, Enrique; Agulló -Ortuño, María Teresa; López-Vacas, Rocío; Díaz, Esther; Camafeita, Emilio; Nistal, Manuel; Madero, Rosario; Espinosa, Enrique; López, Juan Antonio; Vara, Juan Ángel Fresno // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    With the completion of the human genome sequence, biomedical sciences have entered in the "omics" era, mainly due to high-throughput genomics techniques and the recent application of mass spectrometry to proteomics analyses. However, there is still a time lag between these technological advances...

  • PTRF/Cavin-1 and MIF Proteins Are Identified as Non-Small Cell Lung Cancer Biomarkers by Label-Free Proteomics. G�mez-Pozo, Angelo; S�nchez-Navarro, Iker; Calvo, Enrique; Agull� -Ortu�o, Mar�a Teresa; L�pez-Vacas, Roc�o; D�az, Esther; Camafeita, Emilio; Nistal, Manuel; Madero, Rosario; Espinosa, Enrique; L�pez, Juan Antonio; Vara, Juan �ngel Fresno // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    With the completion of the human genome sequence, biomedical sciences have entered in the "omics" era, mainly due to high-throughput genomics techniques and the recent application of mass spectrometry to proteomics analyses. However, there is still a time lag between these technological advances...

  • Genetics and Biological Markers of Risk for Alcoholism. Tabakoff, Boris; Hoffman, Paula L. // Public Health Reports;Nov/Dec88, Vol. 103 Issue 6, p690 

    Substantial scientific evidence has accumulated that both genetic and environmental factors predispose the development of alcoholism in certain individuals. Evidence has accumulated to indicate that alcoholism is a heterogeneous entity arising from multiple etiologies. The demonstrated role of...

  • Genomic markers to tailor treatments: waiting or initiating? Tajik, Parvin; Bossuyt, Patrick M. // Human Genetics;Jul2011, Vol. 130 Issue 1, p15 

    The decade since the publication of the Human Genome Project draft has ended with the discovery of hundreds of genomic markers related to diseases and phenotypes. However, the project has not yet delivered on its promise to tailor treatments for individuals. The number of genomic markers in...

  • Genomic Profiling of Hormone-Naïve Lymph Node Metastases in Patients with Prostate Cancer. Paris, Pamela L.; Hofer, Matthias D.; Albo, Giancarlo; Kuefer, Rainer; Gschwend, Juergen E.; Hautmann, Richard E.; Fridyland, Jane; Simko, Jeffrey; Carroll, Peter R.; Rubin, Mark A.; Collins, Colin // Neoplasia;Dec2006, Vol. 8 Issue 12, p1083 

    The progression of organ-confined prostate cancer to metastatic cancer is inevitably fatal. Consequently, identification of structural changes in the genome and associated transcriptional responses that drive this progression is critical to understanding the disease process and the development...

  • Detection of single nucleotide polymorphisms by PCR conformation-difference gel electrophoresis. Zhu, Weifeng; Deng, Yan; Jie, Kemin; Luo, Daya; Liu, Zhuoqi; Yu, Lehan; Zeng, Erming; Wan, Fusheng // Biotechnology Letters;Apr2013, Vol. 35 Issue 4, p515 

    The most common genetic variations in the human genome, single nucleotide polymorphisms (SNPs), are ideal biomarkers and are used extensively in disease research. Here we introduce a novel method of PCR-conformation-difference gel electrophoresis (PCR-CDGE) used for detecting SNPs. The principle...

  • Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance. Ramos, Yolande F. M.; Metrustry, Sarah; Arden, Nigel; Bay-Jensen, Anne C.; Beekman, Marian; de Craen, Anton J. M.; Cupples, L. Adrienne; Esko, Tõnu; Evangelou, Evangelos; Felson, David T.; Hart, Deborah J.; Ioannidis, John P. A.; Karsdal, Morten; Kloppenburg, Margreet; Lafeber, Floris; Metspalu, Andres; Panoutsopoulou, Kalliope; Slagboom, P. Eline; Spector, Tim D.; van Spil, Erwin W. E. // Journal of Medical Genetics;Sep2014, Vol. 51 Issue 9, p596 

    Background Research for the use of biomarkers in osteoarthritis (OA) is promising, however, adequate discrimination between patients and controls may be hampered due to innate differences. We set out to identify loci influencing levels of serum cartilage oligomeric protein (sCOMP) and urinary...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics